KE3810A - B-lactam antibacterial agents - Google Patents

B-lactam antibacterial agents

Info

Publication number
KE3810A
KE3810A KE3810A KE381088A KE3810A KE 3810 A KE3810 A KE 3810A KE 3810 A KE3810 A KE 3810A KE 381088 A KE381088 A KE 381088A KE 3810 A KE3810 A KE 3810A
Authority
KE
Kenya
Prior art keywords
antibacterial agents
lactam antibacterial
lactam
agents
antibacterial
Prior art date
Application number
KE3810A
Other languages
English (en)
Inventor
Henry Milner Peter
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Publication of KE3810A publication Critical patent/KE3810A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/12—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 3 and unsubstituted in position 7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16—Nitrogen atoms
    • C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D505/00—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
KE3810A 1981-07-25 1988-04-25 B-lactam antibacterial agents KE3810A (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
GB8123033 1981-07-25
GB8123034 1981-07-25
GB8136823 1981-12-07
GB8136824 1981-12-07
GB8207966 1982-03-18
GB8209954 1982-04-03
GB8209953 1982-04-03
GB8215007 1982-05-22

Publications (1)

Publication Number Publication Date
KE3810A true KE3810A (en) 1988-08-05

Family

ID=27571208

Family Applications (1)

Application Number Title Priority Date Filing Date
KE3810A KE3810A (en) 1981-07-25 1988-04-25 B-lactam antibacterial agents

Country Status (18)

Country Link
US (3) US4539149A (el)
EP (1) EP0071395B1 (el)
KR (1) KR900000934B1 (el)
AU (1) AU568062B2 (el)
CA (1) CA1216576A (el)
DE (1) DE3278878D1 (el)
FI (1) FI78702C (el)
GB (1) GB2107307B (el)
GR (1) GR76544B (el)
HK (1) HK58088A (el)
KE (1) KE3810A (el)
MY (1) MY8700744A (el)
NO (1) NO162192C (el)
NZ (1) NZ201369A (el)
PH (4) PH20467A (el)
PL (2) PL145252B1 (el)
PT (1) PT75304B (el)
YU (2) YU43083B (el)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3468027D1 (en) * 1983-01-21 1988-01-21 Beecham Group Plc Beta-lactam antibacterial agents
GB8301694D0 (en) * 1983-01-21 1983-02-23 Beecham Group Plc Beta-lactam antibacterial agents
PH21570A (en) * 1983-01-21 1987-12-11 Beecham Group Plc Process for the preparation of b-lactan compounds
GR79784B (el) * 1983-01-21 1984-10-31 Beecham Group Plc
ES8507556A1 (es) * 1983-01-24 1985-09-01 Beecham Group Plc Un procedimiento para la preparacion de un compuesto de beta-lactama.
EP0131174B1 (en) * 1983-07-07 1989-09-13 Beecham Group Plc Substituted phenylglycine derivatives of beta-lactam antibiotics
JPS6066987A (ja) * 1983-09-20 1985-04-17 Takeda Chem Ind Ltd 抗生物質ｔａν−５４７，その製造法および微生物
EP0150378B1 (en) * 1984-01-23 1990-03-28 Takeda Chemical Industries, Ltd. Cephem compounds and their production
EP0160745A3 (en) * 1984-05-07 1986-11-05 Takeda Chemical Industries, Ltd. Cephem compounds and their production
EP0167011A3 (en) * 1984-06-12 1986-03-19 Beecham Group Plc Beta-lactam compounds, intermediates thereof, their use in preparing beta-lactams having a diketopiperazine group
EP0168177A3 (en) * 1984-06-28 1987-04-01 Pfizer Limited Cephalosporin antibiotics
EP0219926A3 (en) * 1985-06-25 1988-08-31 Beecham Group Plc Cephalosporins, processes for their preparation and pharmaceutical compositions containing them
JPS6230789A (ja) * 1985-08-01 1987-02-09 Yamanouchi Pharmaceut Co Ltd ７−ホルミルアミノセフアロスポリン化合物およびその製造法
EP0211656A3 (en) * 1985-08-10 1988-03-09 Beecham Group Plc Cephalosporin derivatives, process for their preparation and pharmaceutical compositions containing them
GB8531202D0 (en) * 1985-12-18 1986-01-29 Pfizer Ltd Cephalosporin antibiotics
US4666835A (en) * 1986-04-29 1987-05-19 Baldwin Jack E 2-vinylpenams and process
GB8709666D0 (en) * 1987-04-23 1987-05-28 Beecham Group Plc Compounds
GB8719875D0 (en) * 1987-08-22 1987-09-30 Beecham Group Plc Compounds
GB8722477D0 (en) * 1987-09-24 1987-10-28 Beecham Group Plc Compounds
DE3733626A1 (de) * 1987-10-05 1989-04-13 Bayer Ag Heteroanellierte phenylglycin-(beta)-lactam-antibiotika, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
EP0416810B1 (en) * 1989-09-04 1995-02-08 Beecham Group p.l.c. Cephalosporin compounds, process for their preparation, pharmaceutical compositions and intermediates
US7601864B1 (en) * 2008-05-08 2009-10-13 Ufc Corporation Method for synthesizing 4,4-dihalogen-2-(dialkylamino)methylene-3-oxy-alkylbutyrate and derivatives thereof
WO2013057196A1 (en) 2011-10-20 2013-04-25 Dsm Sinochem Pharmaceuticals Netherlands B.V. Process for the preparation of cefamandole nafate
WO2013057197A1 (en) 2011-10-20 2013-04-25 Dsm Sinochem Pharmaceuticals Netherlands B.V. Process for the formylation of cefamandole

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR205683A1 (es) * 1970-06-16 1976-05-31 Merck & Co Inc Procedimiento para la preparacion del ester de bencilo del acido 6-metoxi-6-acilamido penicilanico
GB1442302A (en) * 1972-07-21 1976-07-14 Glaxo Lab Ltd Penicillin and cephalosporin derivatives
US3868365A (en) * 1972-12-06 1975-02-25 Squibb & Sons Inc Method for preparing 6-substituted penicillins by replacement of oxygen containing groups
US4062842A (en) * 1973-09-06 1977-12-13 E. R. Squibb & Sons, Inc. Method for preparing 7-substituted cephalosporins and 6-substituted penicillins by replacement of sulfur-containing groups
US3937655A (en) * 1974-04-16 1976-02-10 Eli Lilly And Company Method for preparing stable β-lactam-type-antibiotic susceptibility test discs
US3962214A (en) * 1974-07-11 1976-06-08 Eli Lilly And Company Process for preparing amino substituted β-lactam antibiotics
US4281117A (en) * 1980-09-04 1981-07-28 Eli Lilly And Company Process for 3-chloro cephalosporin nucleus

Also Published As

Publication number Publication date
CA1216576A (en) 1987-01-13
PH21701A (en) 1988-01-27
PT75304B (en) 1984-07-31
PT75304A (en) 1982-08-01
NZ201369A (en) 1985-12-13
GB2107307A (en) 1983-04-27
GR76544B (el) 1984-08-10
GB2107307B (en) 1986-02-26
FI822606A0 (fi) 1982-07-23
EP0071395B1 (en) 1988-08-10
FI78702C (fi) 1989-09-11
NO162192B (no) 1989-08-14
KR840000559A (ko) 1984-02-25
MY8700744A (en) 1987-12-31
HK58088A (en) 1988-08-05
PL145252B1 (en) 1988-08-31
PL146182B1 (en) 1989-01-31
YU162382A (en) 1985-04-30
YU43083B (en) 1989-02-28
AU568062B2 (en) 1987-12-17
PH20467A (en) 1987-01-14
US4609652A (en) 1986-09-02
PL248815A1 (en) 1985-04-09
FI78702B (fi) 1989-05-31
PH21703A (en) 1988-01-27
FI822606L (fi) 1983-01-26
EP0071395A1 (en) 1983-02-09
YU178484A (en) 1987-12-31
PH21702A (en) 1988-01-27
KR900000934B1 (ko) 1990-02-19
PL237640A1 (en) 1985-01-02
DE3278878D1 (en) 1988-09-15
AU8635182A (en) 1984-10-18
NO162192C (no) 1989-11-22
US4539149A (en) 1985-09-03
NO822538L (no) 1983-01-26
YU45671B (sh) 1992-07-20
US4877783A (en) 1989-10-31

Similar Documents

Publication Publication Date Title
DE3377493D1 (en) Antibacterial agents
ZA85854B (en) Antibacterial agents
MY8700744A (en) B-lactam antibacterial agents
PH23474A (en) Antibacterial agents
GB2097786B (en) Antibacterial agents
GB2102798B (en) Antibacterial penem derivatives
GB2104511B (en) Antibacterial penem deivatives
ZA85853B (en) Antibacterial agents
JPS57150638A (en) Antibacterial
ZW10681A1 (en) Antibacterial agents
ZA825296B (en) Beta-lactam antibacterial agents
ZA824830B (en) Antibacterial penem derivatives
DE3468027D1 (en) Beta-lactam antibacterial agents
GB8310674D0 (en) Antibacterial agents
GB8500843D0 (en) Antibacterial penem derivatives
BG33030A1 (en) Antibacterial means
IE811755L (en) Antibacterial compounds
GB8304956D0 (en) Antibacterial agents
GB8304955D0 (en) Antibacterial agents
GB8304954D0 (en) Antibacterial agents
GB8304988D0 (en) Antibacterial agents
IE811558L (en) B-lactam antibiotics
ZA852365B (en) Antibacterial agents